Marketing Firsts Due As Amryt’s Filsuvez And Roche’s Lunsumio Win EU Nod

No Decision Yet On Eladocagene Exuparvovec And Olipudase Alfa

New drugs are on track to being approved in the EU • Source: Alamy

More from Product Reviews

More from Pink Sheet